Cybin Inc. (HELP)
HELP moved a median of +0.37% 30 minutes after news, and -0.24% by the close. How HELP actually reacts to news — the realized, point-in-time move the market made, measured across 101 labeled events over the last three years with zero look-ahead.
HELP’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 50% | 101 |
| 30-min | +0.37% | 53% | 101 |
| 60-min | +0.31% | 53% | 101 |
| to close | -0.24% | 47% | 100 |
| Middle 50% of HELP reactions | -1.31% to +2.25% |
|---|---|
| Median reaction (30-min) | +0.37% |
| Measured reactions | 101 |
Half of all Cybin Inc. news events land between -1.31% and +2.25% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when HELP moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to HELP's baseline. Nothing else.
Recent HELP events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K Helus Pharma Inc. For: Oct 15 | SEC filing · Form 6-K | SEC EDGAR | -0.29% | +7.18% | |
| Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors | Press release | GlobeNewswire | +0.88% | +7.91% | |
| Form 6-K Helus Pharma Inc. For: Oct 08 | SEC filing · Form 6-K | SEC EDGAR | -1.82% | +2.68% | |
| Helus Pharma to Host Investor Presentation on October 21, 2026 | Press release | GlobeNewswire | -1.82% | +2.68% | |
| Form 6-K Helus Pharma Inc. For: Oct 01 | SEC filing · Form 6-K | SEC EDGAR | -0.53% | +0.79% | |
| Form 6-K Helus Pharma Inc. For: Oct 01 | SEC filing · Form 6-K | SEC EDGAR | -0.17% | -3.46% | |
| Form 6-K Helus Pharma Inc. For: Oct 01 | SEC filing · Form 6-K | SEC EDGAR | +0.07% | -1.33% | |
| Helus Pharma Announces Completion of Legal Name Change | Press release | GlobeNewswire | +0.85% | -3.33% | |
| Form 6-K CYBIN INC. For: Sep 22 | SEC filing · Form 6-K | SEC EDGAR | -2.87% | -4.26% | |
| Form 6-K CYBIN INC. For: Sep 21 | SEC filing · Form 6-K | SEC EDGAR | +0.29% | -1.23% | |
| Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change | Press release | GlobeNewswire | -2.87% | -4.26% | |
| Form 6-K CYBIN INC. For: Sep 21 | SEC filing · Form 6-K | SEC EDGAR | +0.29% | -1.23% | |
| Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026 | Press release | GlobeNewswire | +1.28% | +5.73% | |
| Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit | Press release | GlobeNewswire | +0.29% | -1.23% | |
| Form 6-K CYBIN INC. For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | -0.65% | -1.46% | |
| Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York | Press release | GlobeNewswire | -0.58% | -6.28% | |
| Form 6-K CYBIN INC. For: Sep 09 | SEC filing · Form 6-K | SEC EDGAR | +0.97% | +2.63% | |
| Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York | Press release | GlobeNewswire | +2.59% | +11.13% | |
| Form 6-K CYBIN INC. For: Sep 03 | SEC filing · Form 6-K | SEC EDGAR | -0.59% | +1.91% | |
| Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York | Press release | GlobeNewswire | -0.79% | -1.75% | |
| Form D CYBIN INC. | SEC filing · Form D | SEC EDGAR | +0.24% | -0.36% | |
| Form S-8 CYBIN INC. | SEC filing · Form S-8 | SEC EDGAR | +2.21% | +3.55% | |
| Form 6-K CYBIN INC. For: Aug 18 | SEC filing · Form 6-K | SEC EDGAR | -0.26% | -0.84% | |
| Form D CYBIN INC. | SEC filing · Form D | SEC EDGAR | +1.31% | +3.23% | |
| Form 6-K CYBIN INC. For: Aug 18 | SEC filing · Form 6-K | SEC EDGAR | +0.04% | +3.73% | |
| Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board | Press release | GlobeNewswire | +1.30% | +1.48% | |
| Form 6-K CYBIN INC. For: Aug 14 | SEC filing · Form 6-K | SEC EDGAR | -1.35% | +4.26% | |
| Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights | Press release | GlobeNewswire | -1.35% | +4.26% | |
| Form 6-K CYBIN INC. For: Aug 10 | SEC filing · Form 6-K | SEC EDGAR | -0.20% | +0.80% | |
| Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston | Press release | GlobeNewswire | +0.49% | — | |
| A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout | Press release | GlobeNewswire | -1.51% | +6.47% | |
| Form 6-K CYBIN INC. For: Aug 03 | SEC filing · Form 6-K | SEC EDGAR | -0.13% | +4.27% | |
| Helus Pharma Appoints Michael Halstead as Chief Executive Officer | Press release | GlobeNewswire | -4.05% | +2.02% | |
| Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates | Press release | Canada Newswire | +1.35% | +9.46% | |
| Form 6-K CYBIN INC. For: Jul 21 | SEC filing · Form 6-K | SEC EDGAR | +0.12% | -1.26% | |
| Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule | Press release | GlobeNewswire | +1.35% | +9.46% | |
| Form 6-K CYBIN INC. For: Jun 26 | SEC filing · Form 6-K | SEC EDGAR | +0.35% | -0.14% | |
| Form D CYBIN INC. | SEC filing · Form D | SEC EDGAR | +1.37% | +1.59% | |
| Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity | Press release | GlobeNewswire | +0.74% | -2.36% | |
| Form 40-F CYBIN INC. For: Mar 31 | SEC filing · Form 40-F | SEC EDGAR | +2.36% | +3.30% | |
| Form 6-K CYBIN INC. For: Jun 29 | SEC filing · Form 6-K | SEC EDGAR | +0.74% | -2.36% | |
| Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results | Press release | GlobeNewswire | +2.36% | +3.30% | |
| Form 6-K CYBIN INC. For: Jun 23 | SEC filing · Form 6-K | SEC EDGAR | +3.11% | +17.12% | |
| Form 6-K CYBIN INC. For: Jun 25 | SEC filing · Form 6-K | SEC EDGAR | -0.42% | -1.80% | |
| Form SUPPL CYBIN INC. | SEC filing · Form SUPPL | SEC EDGAR | +3.11% | +17.12% | |
| Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering | Press release | GlobeNewswire | +3.11% | +17.12% | |
| Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress | Press release | GlobeNewswire | +1.25% | -2.12% | |
| Helus Pharma™ Announces US$50 Million Underwritten Offering | Press release | GlobeNewswire | +1.25% | -2.12% | |
| Form 6-K CYBIN INC. For: Jun 11 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.00% | |
| Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference | Press release | GlobeNewswire | -0.25% | +2.79% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the HELP section they belong to.
Where else HELP is measured.
HELP earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cybin Inc.'s median reaction calculated?
Every labeled HELP news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 101 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 53% of HELP's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does HELP's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.